Attached files
| file | filename |
|---|---|
| EX-99.3 - Vyant Bio, Inc. | ex99-3.htm |
| EX-99.2 - Vyant Bio, Inc. | ex99-2.htm |
| EX-99.1 - Vyant Bio, Inc. | ex99-1.htm |
| EX-16.1 - Vyant Bio, Inc. | ex16-1.htm |
| EX-10.7 - Vyant Bio, Inc. | ex10-7.htm |
| EX-10.6 - Vyant Bio, Inc. | ex10-6.htm |
| EX-10.5 - Vyant Bio, Inc. | ex10-5.htm |
| EX-10.4 - Vyant Bio, Inc. | ex10-4.htm |
| EX-10.3 - Vyant Bio, Inc. | ex10-3.htm |
| EX-10.2 - Vyant Bio, Inc. | ex10-2.htm |
| EX-10.1 - Vyant Bio, Inc. | ex10-1.htm |
| EX-4.1 - Vyant Bio, Inc. | ex4-1.htm |
| EX-3.1 - Vyant Bio, Inc. | ex3-1.htm |
| 8-K - Vyant Bio, Inc. | form8-k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-252628, 333-239497, and 333-218229 on Form S-3, Registration Statement Nos. 333-191520, 333-191521, 333-196198, 333-205903, and 333-214599 on Form S-8, and Registration Statement No. 333-215284 on Form S-1 of Vyant Bio, Inc. of our report dated March 30, 2021, relating to the financial statements of StemoniX, Inc. appearing in this Current Report on Form 8-K dated April 5, 2021.
| /s/ DELOITTE & TOUCHE LLP | |
| Minneapolis, Minnesota | |
| April 5, 2021 |